- 3
- 0
- 约1.39万字
- 约 23页
- 2023-09-21 发布于湖北
- 举报
Novel Approaches in Managing Patients
with Hypertrophic Cardiomyopathy
Iacopo Olivotto, MD
27 August 2023
Disclosures - Dr. Olivotto
Research Support: BMS-Myokardia, Cytokinetics, Sanofi Genzyme,
Shire Takeda, Amicus, Bayer, Menarini International, Boston Scientific.
Advisory board, invited speaker: BMS-Myokardia, Cytokinetics, Sanofi,
Genzyme, Shire Takeda, Amicus, Tenaya, Rocket Pharma.
Ho et al, Circulation 2018
3
Heart Failure in HCM Occurs in 2 Contexts
LV Outflow Obstruction
原创力文档

文档评论(0)